Trials / Unknown
UnknownNCT01174407
Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration
Is CD35, CD21 and CD55 Associated With Exudative Age-related Macular Degeneration
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Rudolf Foundation Clinic · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cd 35, cd21, cd55 | Blood drawing/ 10ml/ once- duration of 1 day of full examination of the patient |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-12-01
- Completion
- 2010-08-01
- First posted
- 2010-08-03
- Last updated
- 2010-08-03
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01174407. Inclusion in this directory is not an endorsement.